Peter Smith

Peter Smith

Company: United Therapeutics

Job title: Vice President – Product Development

Seminars:

Uncovering the TETON Phase III Clinical Trial of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis 9:10 am

Reviewing the background on inhaled treprostinil development and potential for treatment in IPF Exploring key study design and attributes of the TETON phase III clinical programRead more

day: Day Two

Panel Discussion: Reflecting on the Progress & Lessons Learned in IPF Clinical Drug Development – Where Will the IPF Road Lead us Next? 11:00 am

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.